全文获取类型
收费全文 | 15840篇 |
免费 | 1175篇 |
国内免费 | 221篇 |
专业分类
耳鼻咽喉 | 248篇 |
儿科学 | 454篇 |
妇产科学 | 149篇 |
基础医学 | 1871篇 |
口腔科学 | 201篇 |
临床医学 | 2003篇 |
内科学 | 3423篇 |
皮肤病学 | 193篇 |
神经病学 | 1395篇 |
特种医学 | 792篇 |
外国民族医学 | 7篇 |
外科学 | 2789篇 |
综合类 | 201篇 |
一般理论 | 9篇 |
预防医学 | 1444篇 |
眼科学 | 220篇 |
药学 | 966篇 |
2篇 | |
中国医学 | 20篇 |
肿瘤学 | 849篇 |
出版年
2023年 | 77篇 |
2022年 | 113篇 |
2021年 | 328篇 |
2020年 | 178篇 |
2019年 | 302篇 |
2018年 | 359篇 |
2017年 | 290篇 |
2016年 | 277篇 |
2015年 | 352篇 |
2014年 | 512篇 |
2013年 | 714篇 |
2012年 | 1025篇 |
2011年 | 1105篇 |
2010年 | 614篇 |
2009年 | 571篇 |
2008年 | 996篇 |
2007年 | 1203篇 |
2006年 | 1036篇 |
2005年 | 1008篇 |
2004年 | 885篇 |
2003年 | 813篇 |
2002年 | 794篇 |
2001年 | 231篇 |
2000年 | 182篇 |
1999年 | 191篇 |
1998年 | 219篇 |
1997年 | 195篇 |
1996年 | 170篇 |
1995年 | 169篇 |
1994年 | 126篇 |
1993年 | 139篇 |
1992年 | 137篇 |
1991年 | 137篇 |
1990年 | 164篇 |
1989年 | 140篇 |
1988年 | 116篇 |
1987年 | 136篇 |
1986年 | 121篇 |
1985年 | 126篇 |
1984年 | 79篇 |
1983年 | 76篇 |
1982年 | 59篇 |
1981年 | 56篇 |
1980年 | 50篇 |
1979年 | 74篇 |
1978年 | 51篇 |
1977年 | 53篇 |
1976年 | 59篇 |
1975年 | 42篇 |
1974年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
82.
Nina Yao Jennifer Turner Zvi Kelman P. Todd Stukenberg Frank Dean David Shechter Zhen-Qiang Pan Jerard Hurwitz Mike O'Donnell 《Genes to cells : devoted to molecular & cellular mechanisms》1996,1(1):101-113
Background: The high speed and processivity of replicative DNA polymerases reside in a processivity factor which has been shown to be a ring-shaped protein. This protein (‘sliding clamp’) encircles DNA and tethers the catalytic unit to the template. Although in eukaryotic, prokaryotic and bacteriophage-T4 systems, the processivity factors are ring-shaped, they assume different oligomeric states. The Escherichia coli clamp (the β subunit) is active as a dimer while the eukaryotic and T4 phage clamps (PCNA and gp45, respectively) are active as trimers. The clamp can not assemble itself on DNA. Instead, a protein complex known as a clamp loader utilizes ATP to assemble the ring around the primer-template. This study compares properties of the human PCNA clamp with those of E. coli and T4 phage. Results: The PCNA ring is a stable trimer down to a concentration below 100 nm (Kd ≈ 21 nm ). On DNA, the PCNA clamp slides freely and dissociates from DNA slowly (t1/2 ≈ 24 min). β is more stable in solution (Kd < 60 pm ) and on DNA (t1/2 ≈ 1 h) than PCNA which may be explained by its simpler oligomeric state. The T4 gp45 clamp is a much less stable trimer than PCNA (Kd ≈ 250 nm ) and requires association with the polymerase to stabilize it on DNA as observed previously. The consequence of this cooperation between clamp and polymerase is that upon finishing a template and dissociation of the polymerase from DNA, the gp45 clamp spontaneously dissociates from DNA without assistance. However, the greater stability of the PCNA and β clamps on DNA necessitates an active process for their removal. The clamp loaders (RF-C and γ complex) were also capable of unloading their respective clamps from DNA in the presence of ATP. Conclusions: The stability of the different clamps in solution correlates with their stability on DNA. Thus, the low stability of the T4 clamp explains the inability to isolate gp45 on DNA. The stability of the PCNA and β clamps predicts they will require an unloading factor to recycle them on and off DNA during replication. The clamp loaders of PCNA and β double as clamp unloaders presumably for the purpose of clamp recycling. 相似文献
83.
Although it is generally accepted that a decrease in plasma oncotic pressure may result in the formation of peripheral edema, the effect of a hypo-oncotic state on brain water content is less well known. Therefore, utilizing the technique of hollow-fiber plasma-pheresis to manipulate plasma composition, the authors examined the effects of acute changes in either plasma osmolality or colloid oncotic pressure on the EEG, regional cerebral blood flow, intracranial pressure, and brain tissue specific gravity (as a measure of cerebral water content) in anesthetized, neurologically normal New Zealand white rabbits. Animals in which either osmolality or oncotic pressure was decreased by plasma replacement with an appropriate solution were compared with a group of control animals in which both of these variables were maintained constant. Animals in which plasma osmolality was decreased by 13 +/- 6 mOsm/kg (from a baseline value of 295 +/- 5 mOsm/kg) showed evidence of a significant increase in cortical water content (approximately 0.5%), whereas a 65% reduction in oncotic pressure (from 20 +/- 2 mmHg to 7 +/- 1 mmHg) failed to produce any change. There were no significant differences in mean arterial pressure, central venous pressure, regional cerebral blood flow, or the EEG between any of the groups. Although intracranial pressure increased in all groups, the largest increase (8.1 +/- 4.4 mmHg) occurred in those animals whose osmolality was reduced. The increase in intracranial pressure in animals rendered hypo-oncotic was no different from the "control" group (2.4 +/- 0.9 mmHg vs. 3.0 +/- 1.5 mmHg).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
84.
Mara L. Leimanis-Laurens Karen Ferguson Emily Wolfrum Brian Boville Dominic Sanfilippo Todd A. Lydic Jeremy W. Prokop Surender Rajasekaran 《Nutrients》2021,13(3)
Lipids are molecules involved in metabolism and inflammation. This study investigates the plasma lipidome for markers of severity and nutritional status in critically ill children. Children with multi-organ dysfunction syndrome (MODS) (n = 24) are analyzed at three time-points and cross-referenced to sedation controls (n = 4) for a total of N = 28. Eight of the patients with MODS, needed veno-arterial extracorporeal membrane oxygenation (VA ECMO) support to survive. Blood plasma lipid profiles are quantified by nano-electrospray (nESI), direct infusion high resolution/accurate mass spectrometry (MS), and tandem mass spectrometry (MS/MS), and compared to nutritional profiles and pediatric logistic organ dysfunction (PELOD) scores. Our results show that PELOD scores were not significantly different between MODS and ECMO cases across time-points (p = 0.66). Lipid profiling provides stratification between sedation controls and all MODS patients for total lysophosphatidylserine (lysoPS) (p-value = 0.004), total phosphatidylserine (PS) (p-value = 0.015), and total ether-linked phosphatidylethanolamine (ether-PE) (p-value = 0.03) after adjusting for sex and age. Nutrition intake over time did not correlate with changes in lipid profiles, as measured by caloric and protein intake. Lipid measurement in the intensive care environment shows dynamic changes over an 8-day pediatric intensive care unit (PICU) course, suggesting novel metabolic indicators for defining critically ill children. 相似文献
85.
Vivolo-Kantor Alana M. Niolon Phyllis Holditch Estefan Lianne Fuino Le Vi Donna Tracy Allison J. Latzman Natasha E. Little Todd D. Lang Kyle M. DeGue Sarah Tharp Andra Teten 《Prevention science》2021,22(2):162-162
Prevention Science - The article “Middle School Effects of the Dating Matters® Comprehensive Teen Dating Violence Prevention Model on Physical Violence, Bullying, and Cyberbullying: a... 相似文献
86.
Somba Magreat Kaaya Sylvia Siril Hellen Oljemark Kicki Ainebyona Donald McAdam Elspeth Todd James Andrew Irene McAdam Keith Simwinga Alice Mleli Neema Makongwa Samwel Haberlen Sabina Fawzi Mary C. Smith 《Prevention science》2021,22(7):940-949
Prevention Science - The NAMWEZA intervention was implemented, using a ten-session group format, to build skills targeting psychosocial vulnerabilities and enhancing HIV prevention among people... 相似文献
87.
Andrea Lin Jasmine A. Mack Brittany Bruggeman Laura M. Jacobsen Amanda L. Posgai Clive H. Wasserfall Todd M. Brusko Mark A. Atkinson Stephen E. Gitelman Peter A. Gottlieb Matthew J. Gurka Clayton E. Mathews Desmond A. Schatz Michael J. Haller 《Diabetes》2021,70(5):1123
Previously, we demonstrated low-dose antithymocyte globulin (ATG) and granulocyte colony-stimulating factor (GCSF) immunotherapy preserved C-peptide for 2 years in a pilot study of patients with established type 1 diabetes (n = 25). Here, we evaluated the long-term outcomes of ATG/GCSF in study participants with 5 years of available follow-up data (n = 15). The primary end point was area under the curve (AUC) C-peptide during a 2-h mixed-meal tolerance test. After 5 years, there were no statistically significant differences in AUC C-peptide when comparing those who received ATG/GCSF versus placebo (P = 0.41). A modeling framework based on mean trajectories in C-peptide AUC over 5 years, accounting for differing trends between groups, was applied to recategorize responders (n = 9) and nonresponders (n = 7). ATG/GCSF reponders demonstrated nearly unchanged HbA1c over 5 years (mean [95% CI] adjusted change 0.29% [–0.69%, 1.27%]), but the study was not powered for comparisons against nonresponders 1.75% (–0.57%, 4.06%) or placebo recipients 1.44% (0.21%, 2.66%). These data underscore the importance of long-term follow-up in previous and ongoing phase 2 trials of low-dose ATG in recent-onset type 1 diabetes. 相似文献
88.
89.
90.
Ashley Lacombe-Duncan PhD MSW Hannah Kia PhD MSW Carmen H. Logie PhD MSW Kieran P. Todd BA Yasmeen Persad Gabrielle Leblanc Kelendria Nation Ayden I. Scheim PhD Tara Lyons PhD Chavisa Horemans MES BFA Mona Loutfy MD FRCPC MPH 《Health & social care in the community》2021,29(5):e33-e46
Transgender (trans) women experience barriers to access to HIV care, which result in their lower engagement in HIV prevention, treatment and support relative to cisgender people living with HIV. Studies of trans women's barriers to HIV care have predominantly focused on perspectives of trans women, while barriers are most often described at provider, organisation and/or systems levels. Comparing perspectives of trans women and service providers may promote a shared vision for achieving health equity. Thus, this qualitative study utilised focus groups and semi-structured interviews conducted 2018–2019 to understand barriers and facilitators to HIV care from the perspectives of trans women (n = 26) and service providers (n = 10). Barriers endorsed by both groups included: (a) anticipated and enacted stigma and discrimination in the provision of direct care, (b) lack of provider knowledge of HIV care needs for trans women, (c) absence of trans-specific services/organisations and (d) cisnormativity in sexual healthcare. Facilitators included: (a) provision of trans-positive trauma-informed care, (b) autonomy and choice for trans women in selecting sexual health services and (c) models for trans-affirming systems change. Each theme had significant overlap, yet nuanced perspective, between trans women and service providers. Specific recommendations to improve HIV care access for trans women are discussed. These recommendations can be used by administrators and service providers alike to work collaboratively with trans women to reduce barriers and facilitators to HIV care and ultimately to achieve health equity for trans women. 相似文献